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1. Introduction 
The rate-limiting step of adrenal and gonadal 
steroidogenesis is the conversion of cholesterol to 
pregnenolone [1-3]. There is good evidence that 
most of the steroidogenic compounds activate the 
steroid biosynthetic pathway at a site prior the for- 
mation of pregnenolone [4-6]. This effect of the 
steroidogenic compounds in both adrenals and gonads 
requires protein synthesis, ince cycloheximide inhibits 
the transformation f cholesterol to pregnenolone 
[1,7] and increases the accumulation of unconjugated 
cholesterol in the cytosol [8]. It has been postulated 
[1 ] that the steroidogenic compounds stimulate 
steroidogenesis by regulating a protein which trans- 
locates cholesterol from cytosol to mitochondria, but 
such a protein has not been identified. 
We report here the presence of a heat stable protein 
in the cytosol of adrenal, testicle and ovary, which 
specifically binds cholesterol and some of its deriva- 
tives, but which does not recognize the compounds 
without the side chain of cholesterol. 
Abbreviations: CBP, cholesterol-binding protein; cholesterol, 
5-cholesten-3/3ol; (20S) 20-hydroxycholesterol, (20 S) 
5 cholesten-3/3, 20-diol; (20 R, 22 R) 20,22-dihydroxy- 
cholesterol, (22 R) 5 cholesten-3/320c~22-triol; (20 R, 22 S) 
20,22-dihydroxycholesterol; (22 S) 5 cholesten-3020a22- 
triol; pregnenolone, 5 pregnen-3f3ol-20-one; progesterone, 
4-pregnene-3,20 dione; dehydroepiandrosterone, 3/~-hydroxy- 
5-androsten-17-one; testosterone, 17~ hydroxyandrost-4-ene- 
3-one; cortisol, 4-pregnen-11/3, 17a, 21 triol-3,20-dione; 
17-oestradiol, 1,3,5(10) oestratriene-3,17~-diol; 25-hydroxy- 
cholesterol, 5-cholesten-3~3, 25-dioi 
2. Materials and methods 
2.1. Partial purification o f  adrenal cholesterol-binding 
protein 
All tissues were homogenized in 50 mM Tris-HC1 
buffer, pH 7.4 and centrifuged to 105 000 × g for 
90 min. The supernatant was slowly added to 10 vol. 
cold acetate (-60°C) and centrifuged to 10 000 × g 
for 10 rain. The pellet was washed once with cold 
acetone and once with cold ethyl ether (-60°C), 
and finally dried under vacuum. The acetone powder 
was resuspended in Tris-HC1 buffer heated at 100°C 
for 5 min and centrifuged. The supernatant was 
saved (heat-stable cytosol). The proteins of this 
fraction were precipitated by addition of ammonium 
sulfate to 30% saturation. After centrifugation, more 
ammonium sulfate was added to reach 60% satura- 
tion and centrifuged. The pellet of each centrifuga- 
tion was redissolved in 50 mM Tris-HC1 buffer, 
pH 7.4 and dialyzed against he same buffer. The 
fraction precipitated by 60% ammonium sulfate was 
chromatographed on a DEAE-Sephadex A 50 column 
(20 × 1.5 cm) pre-equilibrated in 50 mM Tris-HCl 
buffer. After washing the column was eluted by a 
continuous gradient of NaC1 (0--0.5 M). In some 
cases, the fraction precipited by 60% ammonium 
sulfate was preincubated with [3H]cholesterol 
(spec. act. 43 Ci/mmol; Amersham, England) before 
chromatography on DEAE-Sephadex. 
2.2. Binding assays 
Celite 454 was extensively washed with 6 N HC1, 
distilled water, and distilled methanol. After activa- 
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tion at 600°C for 12 h, 50 mg aliquots were distributed 
in small tubes. Labeled and unlabeled sterols dissolved 
in benzene were layered on celite and then the solvent 
was dried under vacuum. The protein fraction in 
50 mM Tris-HC1 buffer was added to the tubes 
containing the celite and sterols and shaken for the 
times and at the temperatures indicated in the fig. 1 -6  
and tables 1,2. At the end of the incubation the tube 
was centrifuged at 10 000 × g for 10 min. An aliquot 
of the supernatant was used for determination of the 
radioactivity, another was layered over a sucrose 
gradient (5-20%) prepared in Tris-HC1 buffer con- 
taining 10% glycerol (v/v)and centrifuged for 30-40 h 
at 250 000 X g. 
All binding determinations u ing the celite system 
were performed in triplicate. Three additional samples 
were also measured in the presence of a 100-fold 
excess of unlabeled cholesterol. 
3. Results 
Table 1 
Specific binding of [3H]cholesterol by several preparations 
of sheep adrenal cytosol 
fmol/0.1 mg protein 
Acetone powder 20 ± 10 
Heat-stable cytosol 
acetone powder 1080 +- 204 
Ammonium sulfate 
precipitated (0-30% satn) 220 -+ 40 
Ammonium sulfate 
precipitated (30-60% satn) 2580 +- 400 
DEAE-Sephadex 4240 +- 500 
Tris-HC1 buffer, 1 m150 raM, containing 0.5 mg protein of 
the indicated cytosol preparation, was incubated with 50 mg 
celite containing l 0 pmol [31-1]cholesterol, without or with 
1 nmol unlabeled cholesterol at 4°C for 16 h and centrifuged 
at 10 000 × g for 10 min. An aliquot was taken for protein 
determination, another was layered over a sucrose gradient 
(5-20%) and centrifuged at 250 000 × g for 36 h. The 
specific binding represents he integration of radioactivity 
under the 3 S peak. The results are the mean -+ SD of 3 
different determinations 
Cholesterol content of sheep adrenal cytosol is 
very high (4-8/ag/mg protein, 5 expt). Therefore, to 
study the binding of [3H]cholesterol toadrenal cytosol, 
it was crucial to extract endogenous cholesterol with- 
out protein degradation. After acetone precipitation, 
more than 99% cytosol cholesterol was recovered in 
the pool of  organic solvents and cholesterol was 
undetectable in the acetone powder. Heating at 100°C 
for 4 min precipitated 90-95% resuspended acetone 
powder proteins. The recovery of the cholesterol- 
binding protein was almost complete as indicated by 
the measurement of its binding activity (table 1). 
3.1. Binding of [ 3H]cholesterol to heat stable adrenal 
cy tosol pro reins 
The classical methods used to separate unbound 
from bound steroids, such as dextran-coated charcoal, 
ammonium sulfate precipitation, or equilibrium 
dialysis do not give reproductible results when used 
to separate bound from unbound cholesterol. Nor 
did gel filtration on Sephadex G-75 or G-100 columns 
(1 × 10 cm) separate bound from unbound cholesterol. 
When heat-stable cytosol was incubated at 4°C or 37°C 
with [3H]cholesterol (10 -9 M) in the absence or 
presence of unlabeled cholesterol (10-7 M), then 
chromatographed on Sephadex at 4°C most of the 
radioactivity came out in the void volume. Moreover, 
similar results were obtained when 50 mM Tris-buffer 
alone, rather than the heat-stable cytosol was used. 
When the celite system was used [3H]cholesterol 
bound to heat-stable cytosol was displaced by unlabeled 
cholesterol (fig.l). Sucrose density gradient ultra- 
centrifugation of the soluble complex formed during 
incubation of the heat stable cytosol with celite 
containing [3H]cholesterol reveals that most of the 
radioactivity is bound to a macromolecule in the 
region of 3 S (fig.2). The specificity of the binding 
was inferred by the fact that a 100-fold excess of 
unlabeled cholesterol completely inhibits the radio- 
active peak in the 3 S region (fig.2). 
Preincubation of heat stable cytosol with trypsin 
or pronase at 37°C for 30 min completely abolished 
the radioactive peak (fig.2). This result demonstrates 
that the macromolecule which binds [3H]cholesterol 
is a protein. 
It should be emphasized that the combined celite- 
sucrose gradient assay is more specific than celite 
alone, since a 100-fold excess of unlabeled cholesterol 
completely inhibits the binding in the former system 
but not in the latter (compare the displacement 
produced by 10 -7 M in fig.1 with fig.2). 
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Fig.1. Displacement of [SH]cholesterol bound to heat-stable 
sheep adrenal cytosol by increasing concentrations of unlabeled 
cholesterol. Heat stable adrenal cytosol, 1 ml (0.5 mg protein) 
was incubated at 4°C for 16 h with 50 mg celite containing 
[3H]cholesterol and the indicated concentrations of choles- 
terol. At the end of the incubation the samples were centri- 
fuged and 2 aliquots of each of triplicate incubations were 
taken for determination the radioactivity. 
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Fig.2. Sucrose density gradient ultracentrifugation profiles 
of adrenal heat-stable cytosol (0.4 mg protein/ml) (e, -), 
adrenal heat-stable cytosol treated with trypsin or pronase 
(o), preincubated with oolite containing [3H]cholesterol 
(1 pmol) alone (e, o), or with 100-fold excess of unlabeled 
cholesterol (A). At the end of incubation (14 h, 4°C) the 
samples were centrifuged and an aliquot of the supernatant 
was layered on 5-20% sucrose gradient and centrifuged 
at 250 000 X g for 38 h. 
3.2. Partial purification of adrenal cholesterol binding 
protein (CBP) 
Most of the cholesterol binding activity is recovered 
in the protein fraction precipitated between 30-60% 
saturation of ammonium sulfate (table 1). 
The elution profile of the DEAE Sephadex A-50 
column chromatography shows that the cholesterol- 
binding activity was associated with the fraction eluted 
with about 0.3 M NaC1 (fig.3). About 200-fold purifi- 
cation was reached at this step (table 1). 
3.3. Specificity of binding 
Competition studies using the combined cel ite- 
sucrose gradient system were carried out in order to 
determine the degree of specificity of cholesterol 
binding to CBP. 
The addition of a 100-fold excess of non-radio- 
active steroids without he side chain of cholesterol 
had no inhibitory effects (table 2). In addition, when 
CBP was incubated with [aH]pregnenolone or [3H]de- 
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Fig.3. Elution profile of cholesterol-binding protein on 
DEAE Sephadex A-50 column. Proteins of adrenal heat 
stable cytosol precipitated by ammonium sulfate (30-60% 
saturation) were incubated with [ 3H ]cholesterol (10- 9 M) 
at 4°C for 16 h and placed on 1.5 × 20 cm DEAE-Sephadex 
column. Elution was monitored at 280 nm (o) and aliquots 
from each fraction analyzed for radioactivity (e). 
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Table 2 
Effects of unlabeled sterols and steroids on specific binding 
of [3H]cholesterol t  CBP prepared from sheep adrenal 
Unlabeled compounds Binding (% control) 
None 100 
Dehydroepiandrosterone 100 
Progesterone 100 
Pregnenolone 100 
Testosterone. 100 
Cortisol 100 
17t3-Oestradiol 100 
25-Hydroxycholesterol 30 
(20 S)20 hydroxycholesterol 21 
(20 R, 22 S)20-22 dihydroxycholesterol 18
(20 R, 22 R)20-22 dihydroxycholesterol 9 
7-Carboxy-methyl-oxime-cholesterol 0
4-Methyl-4-aza-5a-cholestane 0 
Cholesterol sulfate 0 
Cholesterol 0 
CBP, 1 ml (0.7 mg protein) was incubated at 4°C for 16 h 
with 50 mg celite containing [3H]cholesterol (1 pmol) 
alone, or with a 100-fold excess of unlabeled compounds. 
After centrifugation, aliquots of the supernatant were 
layered on a 5-20% sucrose gradient, and centrifuged at
250 000 × g for 38 h. The radioactivity in the 3 S region 
was integrated, and expressed as % control 
hydroepiandrosterone no specific binding was observed 
in the 3 S region (data not shown). 
On the other hand, cholesterol derivatives with 
modifications in the A and B rings such as 7-carboxy- 
methyloxime-cholesterol, 4 methyl4aza-5a-cholestane 
and cholesterol sulfate have the same inhibitory 
potency as those observed with the cholesterol itself 
(table 2). 
The inhibitory effect of cholesterol derivatives with 
hydroxylated groups on the side-chain is shown in 
table 2, riga and fig.5. (20 R, 22 R)20-22 dihydroxy- 
Fig.5. Inhibition of [all]cholesterol bound to CBP by several 
cholesterol derivatives. Partial purified CBP, 1 ml (0.58 mg 
protein) was incubated with 50 mg celite containing [3H]cho- 
lesterol (1 pmol), alone (.), or in the presence of 100 pmol 
(20 R, 22 S)20,22-dihydroxycholesterol (a), and (20 R, 
22 R)20,22-dihydroxycholesterol (a). At the end of incuba- 
tion (14 h, 4°C) the samples were centrifuged and an aliquot 
of the supernatant was layered on 5-20% sucrose gradient 
and centrifuged at 260 000 × g for 38 h. 
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Fig.4. Inhibition of [all]cholesterol bound to CBP by several 
cholesterol derivatives. Partial purified CBP, 1 ml (0.58 mg 
protein) was incubated with 50 mg celite containing [3H]- 
cholesterol (1 pmol) alone (.), or in the presence of 100 pmol 
(20 S)20-hydroxycholesterol (.), and cholesterol (o). At 
the end of incubation (14 h, 4°C) the samples were cen- 
trifuged and an aliquot of the supernatant was layered on 
5-20% sucrose gradient and centrifuged at260 000 × g 
for 38 h. 
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cholesterol isa better competitor than its stereoisomer 
(20 R, 22 S)20-22 dihydroxycholesterol. The inhibitory 
effect of 25 hydroxycholesterol and (20 S) 
20-hydroxy-cholesterol is lower than that of choles- 
terol hydroxylated in C2o and C22, which is in turn 
lower that of cholesterol itself. 
3.4. CBP tissue distribution 
Heat-stable cytosol was prepared from several 
tissues and tested for their ability to bind cholesterol. 
Using the combined celite-sucrose density gradient 
system, cholesterol-binding activity was found in 
adrenals (human, rat, sheep), testis and ovaries (rats, 
sheep) (fig.6). On the other hand, no binding activity 
was found in the heat-stable cytosol prepared from 
liver, kidney, heart, brain and plasma of rats or sheep 
(fig.6). 
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Fig.6. Sucrose density gradient ultracentrifugation profiles 
of heat stable cytosol (0.4 mg protein/ml) from rat adrenals 
(o), testis (A), ovaries (zx), and liver, heart, kidney, brain and 
plasma (¢), preincubated with celite containing [ 3H ]choles- 
terol (1 pmol). At the end of incubation (14 h, 4°C), the 
samples were centrifuged and an aliquot of the supernatant 
was layered on 5-20% sucrose gradient and centrifuged 
at 250 000 X g for 38 h. 
4. Discussion 
In this report, we have shown the presence in the 
cytosol of adrenal, testis, and ovaries of a heat-stable 
protein that specifically binds tritiated cholesterol. 
As determined by sucrose density gradient ultra- 
centrifugation, the sedimentation coefficient of the 
complex formed is about 3 S. This cholesterol-binding 
protein (CBP) has been partially purified, about 
200-fold, from the acetone powder by heat treatment, 
ammonium sulfate precipitation, and DEAE Sephadex 
A-50 chromatography. 
Quantitation of binding affinity was rendered 
difficult by the affinity of cholesterol for glass and 
plastic and its tendency to self-association with a 
critical micelle concentration of about 35 nM at 25°C 
[9]. For these reasons, and because in the celite 
system there are at least two binding molecules 
(celite, CBP), competing for the same ligand, mathe- 
matical analyses of competitive displacement curves 
(fig.l) or saturation curves (data not shown) was not 
possible. It must be noted that similar difficulties have 
been found for other sterols [10]. 
None of the steroids without side-chain that were 
tested were able to displace bound radioactive choles- 
terol to CBP. On the other hand, sterols with modifi- 
cation in the rings A or B inhibited the binding of 
tritiated cholesterol as well as unlabeled cholesterol 
itself, suggesting that the side-chain is essential for 
binding. In this respect it is interesting to note that 
(20 R, 22 R)20,22 dihydroxycholesterol, which is 
the natural intermediate in the enzymatic onversion 
of cholesterol to pregnenolone [11 ], is a better com- 
petitor than its stereoisomer, (20 R, 22 S)-20,22 
dihydroxycholesterol, which has no metabolic role. 
A heat-stable sterol carrier protein which binds 
cholesterol has been isolated from the soluble frac- 
tion of liver homogenates [ 12-t  4]. This heat-stable 
factor stimulates the synthesis of cholesterol by liver 
microsomal enzymes [12,14] and the cholesterol 
side-chain cleavage of an acetone powder of adrenal 
mitochondria [ 15]. A similar heat stable sterol carrier 
protein in adrenal mitochondria is reported [16,17]. 
As indicated, using a different method we were able 
to demonstrate a cholesterol-binding activity in the 
heat-stable cytosol prepared from adrenal, ovary 
and testis, but not from liver, kidney, brain and heart. 
Therefore, despite the fact that some of the properties 
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of liver and adrenal heat-stable factors [ 12,14,16 ] are 
close to those of CBP, some are different, i.e., CBP has 
mol. wt ~ 70 000 (in preparation) while that of liver 
sterol-carrier p otein is "" 16 000 [10]. The specificity 
of  CBP binding is localized mainly to the side chain 
of  cholesterol, while that of liver sterol carrier protein 
seems to be less specific [10]. 
The role of  CBP on hormone induced steroido- 
genesis of both adrenals and gonads is unknown. 
However, the binding stereospecificity and the tissue 
distribution suggest that CBP might play an important 
role. However purification to homogeneity of CBP in 
view to set up a specific and sensitive method of 
measurement is the next necessary step for studying 
its precise role in vivo. 
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